SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-001965
Filing Date
2019-01-15
Accepted
2019-01-15 17:15:44
Documents
3
Period of Report
2019-01-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-2961_18k.htm 8-K 40185
2 EX-10.1 a19-2961_1ex10d1.htm EX-10.1 101353
3 EX-99.1 a19-2961_1ex99d1.htm EX-99.1 17419
  Complete submission text file 0001104659-19-001965.txt   160391
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 19527660
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences